Next Article in Journal
Morphological Assessment of Nasopalatine Canal Using Cone Beam Computed Tomography: A Retrospective Study of 124 Consecutive Patients
Previous Article in Journal
Comprehensive In Silico Characterization of the Coding and Non-Coding SNPs in Human Dectin-1 Gene with the Potential of High-Risk Pathogenicity Associated with Fungal Infections
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Functional Magnetic Resonance Urography in Children—Tips and Pitfalls

by
Małgorzata Grzywińska
1,
Dominik Świętoń
2,*,
Agnieszka Sabisz
2 and
Maciej Piskunowicz
3
1
Applied Cognitive Neuroscience Lab., Department of Neurophysiology, Neuropsychology and Neuroinformatics, Medical University of Gdansk, 80-210 Gdansk, Poland
2
2nd Department of Radiology, Medical University of Gdansk, 80-210 Gdansk, Poland
3
1st Department of Radiology, Medical University of Gdansk, 80-210 Gdansk, Poland
*
Author to whom correspondence should be addressed.
Diagnostics 2023, 13(10), 1786; https://doi.org/10.3390/diagnostics13101786
Submission received: 23 April 2023 / Revised: 13 May 2023 / Accepted: 15 May 2023 / Published: 18 May 2023
(This article belongs to the Topic Medical Image Analysis)

Abstract

:
MR urography can be an alternative to other imaging methods of the urinary tract in children. However, this examination may present technical problems influencing further results. Special attention must be paid to the parameters of dynamic sequences to obtain valuable data for further functional analysis. The analysis of methodology for renal function assessment using 3T magnetic resonance in children. A retrospective analysis of MR urography studies was performed in a group of 91 patients. Particular attention was paid to the acquisition parameters of the 3D-Thrive dynamic with contrast medium administration as a basic urography sequence. The authors have evaluated images qualitatively and compared contrast-to-noise ratio (CNR), curves smoothness, and quality of baseline (evaluation signal noise ratio) in every dynamic in each patient in every protocol used in our institution. Quality analysis of the image (ICC = 0.877, p < 0.001) was improved so that we have a statistically significant difference in image quality between protocols (χ2(3) = 20.134, p < 0.001). The results obtained for SNR in the medulla and cortex show that there was a statistically significant difference in SNR in the cortex (χ2(3) = 9.060, p = 0.029). Therefore, the obtained results show that with the newer protocol, we obtain lower values of standard deviation for TTP in the aorta (in ChopfMRU: first protocol SD = 14.560 vs. fourth protocol SD = 5.599; in IntelliSpace Portal: first protocol SD = 15.241 vs. fourth protocol SD = 5.506). Magnetic resonance urography is a promising technique with a few challenges that arise and need to be overcome. New technical opportunities should be introduced for everyday practice to improve MRU results.

1. Introduction

Imaging of the urinary system in children is mainly based on ultrasound (US), classical roentgenography, and scintigraphy. Each of these methods has its advantages as well as limitations [1,2,3]. Ultrasound is an optimal tool for visualizing kidneys, and their collecting systems are safe and commonly available. However, this method does not carry information about the renal function. Whereas classic roentgenography gives enough proper morphological evaluation of the collecting system and indirect information about the renal function. Unfortunately, in this method, we have a radiation burden, and unavoidable is the use of contrast media [4].
Another method used for imaging the urinary tract is computed tomography (CT). When the acquisition of images has become faster, this method has gained popularity; however, still limited due to radiation exposure and usage of an iodine contrast [5,6].
The gold standard in imaging renal function and determining split renal function is scintigraphic imaging with the use of a radionuclide Technetium-99m-mercaptoacetyltriglycine (99mTc-MAG3). This method, like the previous ones, has a few disadvantages—limitations in the detection of small subjects, low spatial and contrast resolution (inadequate anatomic information), usage of radionuclides, and hence ionizing radiation [7], which is why we are looking for an alternative.
Like Uro-CT, magnetic resonance urography (MRU) gives the possibility of assessing renal parenchyma, collecting systems, ureters, and bladder. The better signal, excellent contrast resolution, and lack of ionizing radiation make MRU a promising examination for non-invasive assessment of the urinary tract. However, it still requires a contrast medium, and it does not exceed Uro-CT in spatial resolution, as well as has a lower sensitivity for imaging renal stones [8,9,10].
Functional analysis of the MRU scan still requires external post-processing with relatively complicated software. It can be a limiting factor in the full routine implementation of functional analysis of the MRU, and the use of functional parameters of MRUs comparable to nuclear medicine [4,7,11,12,13,14].
MRU allows quantifying the perfusion of the parenchyma and glomerular filtration and visualizing of kidney excretory functions as well as urination [9,10,14,15,16]. All these advantages make MRU ideally suited for a comprehensive assessment of the upper urinary tract. However, the need for children’s anesthesia is still the main limitation [10,17,18].
For dynamic sequences, we use T1-weighted images followed by a paramagnetic intravenous contrast agent based on gadolinium. These sequences are usually preceded by diuretic injection approximately 15 min before contrast administration at a dose of 0.25 to 0.5 mg/kg body weight. The dynamic sequence is being performed in the coronal plane, which allows for assessing the anatomy of large kidney vessels, parenchyma, and collecting systems [4,17]. The imaging needs fat suppression to increase the visibility of the ureters. In this technique, the recommended (ESUR, Contrast Media Safety Guidelines 10.0) dose of gadolinium is 0.1 mmol/kg [19] (in our case: Gadobutrolum at flow rate of 0.5 mL/s). The use of diuretics is a supplement that can improve the excretion of the contrast agent and allows its greater dilution [20,21]. Contraindications for contrast agent use are: anuria, hypersensitivity to the drug, electrolyte imbalance, or hypotension and are cautious in patients allergic to sulphonamides. MRU technique can be performed in conjunction with a conventional MR for an integrated assessment of the urinary tract.
However, pediatric MRU has some limitations: structures are much smaller than adult structures, heart rate, and respiratory frequency are higher than in adults, and patients are less likely to cooperate. Due to these adversities, acquisition parameters should be adjusted precisely to optimize the spatial and temporal resolution, and to make the acquisition time relatively short, but together with the right results. Therefore, imaging protocols and specific sequence parameters often need to adjust for the patients [4,22,23].
The aim of this study was the analysis of methodology for renal function assessment using 3T magnetic resonance imaging in children.

2. Materials and Methods

2.1. Subjects

A retrospective analysis of MRU 3D-Thrive dynamic sequence with contrast injection was performed on 91 patients (55 female, 36 male, mean age: 6.00 ± 5.84, range: 6 months–17 years).
The research was according to the Helsinki Declaration of 1975, as revised in 2000.

2.2. Imaging Protocol Evaluation

The examinations were performed using a Philips Achieva 3T TX magnetic resonance scanner (Philips Healthcare; Best, The Netherlands) with 16-channel coil dedicated to abdominal examinations.
After taking the localizer sequence (a set of three-plane, low-resolution, large field-of-view images to localize part of the body to examination), morphological imaging sequences were acquired in three directions to provide anatomical orientation. The protocol included 3D thrive dynamic sequence for functional analysis. This sequence was changing over time; mainly, we changed parameters, such as matrix, the number of signals averaged (NSA), flip angle (FA), and number of dynamics. Every single examination was fitted for each patient to optimize time and spatial resolution—such as the field of view (FOV), and number of slices. Patients differ in age, weight, and height, which had an impact on the image signal and quality. Thus, we can put in approximate acquisition parameters (Table 1).
For optimization time resolution and the acquisition matrix, we did use thinner slice, higher matrix, SENSitivity Encoding (SENSE), and recently we add ENCASE (Enhanced Coronal Acquisition with Sagittal Excitation [24]).
Both the protocol and the dynamic sequence were successively changed according to our knowledge, experience, and current technical possibilities (Table 1 and Table 2). The analysis was performed on images obtained in the dynamic schema with 3D-THRIVE sequence with the administration of the contrast agent.

2.3. Assessment of Image Quality

Both kidneys were used for analysis. Image quality was performed on dynamic sequences before contrast by two examinators assessing in consensus. Visual assessment was performed by using scale of the visibility of corticomedullary differentiation in the time (1—poor, 2—moderate, 3—good, 4—excellent) [25,26]. The data were randomized for each author.

2.4. Contrast-to-Noise Ratio (CNR) and Signal-to-Noise-Ratio (SNR) Measurements

Contrast-to-noise ratio (CNR) and signal-to-noise-ratio (SNR) [27] is a measure used to determine image quality. This measurement was obtained with ROI (region of interest), which was placed in the cortex and medulla in the upper part of the kidney. ROI was as large as possible (Figure 1). The data were taken on the four places with the same size ROI in medulla and cortex and then averaged. Signal intensity on background noise was taken in the four ROIs in the background away from the body. CNR was calculated using the following formula [3,28]:
C N R = S N R c o r t e x S N R m e d u l l a
In our case, when we use parallel image acquisition, SNR was defined as a relative mean signal in each subject divided by the standard deviation in the background.

2.5. Signal Intensity Curves Evaluation

Passing the contrast in time through specific anatomical parts of the kidneys can be represented by the changes in signal intensity curves depending on time from a specific ROI (Figure 1). This analysis was carried out in the Philips IntellinSpace Portal program. From the semiquantitative analysis, we can obtain information about relative enhancement, maximum enhancement, maximum relative enhancement, T0 (time of contrast in-flow), time to peak (time between the time of contrast inflow and time with a maximum of enhancement), wash in rate, washout rate, the brevity of enhancement, the area under the curve. However, for our needs, we used only T0 and TTP, to calculate RTT, and CTT in each kidney.
Functional analysis of kidneys was carried out in the program ChopfMRU (v 1.11, the Department of Radiology, at The Children’s Hospital of Philadelphia, https://www.parametricmri.com/ accessed on 17 May 2023) [9], which works on IDL Machine. Firstly, files of the MRU scan are exported into a single directory using free program DicomWorks® (version 1.3.5, dicomworks.com accessed on 17 May 2023) [17] (Figure 2) and sorted.
The analysis in the ChopfMRU program has been divided into three stages:
  • Separation of the aorta (Figure 3)—the number of time points was found so that the aorta was marked significantly against the background of the organs (the moment of the highest signal intensity in the vessel),
  • Separation of the kidneys (Figure 4)—the number of time points was found where contrast is first seen in the calyces,
  • Biophysical model analysis (Figure 5)—estimation of functional parameters for the aorta and each kidney.
From the biophysical model, the analysis included Patlak–Rutland method we can obtain information that was described by Khrichenko et al. [29]. For our usage, we focused on parameter: time to peak (TTP; time to achieve the maximum enhanced of the parenchyma; calculated automatically).
The analysis of curves of signal intensity as a function of time from the ChopfMRU program was qualitatively compared by two authors with the curves obtained in the Philips IntelliSpace Portal program (Figure 6). The authors have evaluated qualitatively and compared contrast noise ratio (CNR), curves smoothness, and quality of baseline (evaluation signal noise ratio) in every dynamic in each patient in every protocol.

2.6. Statistical Analysis

The agreement between observers was measured by ICC (intraclass correlation coefficient). All results were tested for normal distribution with the Shapiro–Wilk test for each protocol. To improve the difference between data obtained with a different protocol, we used the Kruskal–Wallis H test and used U Manna–Whitney test to compare data between protocols, where Kruskal–Wallis H test shows a significant difference. The statistical analysis was prepared in IBM SPSS 25.0 (SPSS, Inc., Chicago, IL, USA).

3. Results

3.1. Evaluation of Imaging Techniques

In the first of three protocols, we used dynamic sequences of the angle of the oblique-coronal plane. At the fourth, the maximum angle of the plane can be 5 degrees, because we use ENCASE and for this angulation from the coronal orientation is limited to +/−5 degrees for all directions. However, we used this modality mainly to suppress the breathing artifacts.
We placed the patient with his or her hands up; this allowed us to adjust the kidney’s long axis, thus compensating for the restriction—the second problem which we have a problem with analysis enhanced plot. We increased the number and frequency of consecutive dynamics in the initial phase. For the first protocol, we had 30 s break between dynamics, while in the fourth protocol, we use for beginning, dynamics were acquired one by one, without interruption. Then a few minutes of scanning—30 s break. Thanks to that, we have more information about kidney perfusion from the first minutes after contrast injection until notice a contrast in the ureter below the lower pole of the kidney.

3.2. Assessment of Image Quality

The agreement between observers was 0.877 (a high intraclass correlation coefficient) with p < 0.001. Therefore, the results in Table 3 present descriptive statistics of data collected by one observer. The results for each protocol were tested for normal distribution with the Shapiro–Wilk test. This test showed that obtained data do not have a normal distribution (p < 0.05). Hence, gain data were tested with the Kruskal–Wallis H test. This test shows that there was a statistically significant difference in image quality between protocols (χ2(3) = 20.134, p < 0.001). To improve which group of the protocols is a significant difference (Figure 7), we used the U Manna–Whitney test. We obtained that the significant difference was between the first and fourth protocol (Z = −3.423, p = 0.001), the second and third (Z = −2.323, p = 0.020), second and fourth (Z = −4.212, p < 0.001).

3.3. Contrast-to-Noise Ratio (CNR) and Signal-to-Noise-Ratio (SNR) Measurements

Results of signal-to-noise-ratio (SNR) and contrast-to-noise-ratio (CNR) for each protocol did not have a normal distribution (p < 0.05). The mean value of CNR was almost the same for every protocol (Table 4) (Figure 8, Figure 9 and Figure 10). However, the median in the fourth protocol had the highest value, and this may indicate a better contrast of the image in this protocol. By analyzing the results obtained for SNR in medulla and cortex (Table 5), we can expect significant differences between the older protocols and the latest ones.
Therefore, obtained data were tested with the Kruskal–Wallis H test. This test shows that there was a statistically significant difference in SNR in the cortex (χ2(3) = 9.060, p = 0.029) and medulla (χ2(3) = 8.114, p = 0.44) between protocol, but in CNR we do not obtain the significant difference between protocols (χ2(3) = 4.542, p = 0.209).
To improve which group of the protocol is a significant difference in SNR, we used the U Manna–Whitney test. We obtained that the significant difference was in the:
  • Cortex: 2nd and 3rd (Z = −2.429, p = 0.015), 2nd and 4th (Z = −2.626, p = 0.009),
  • Medulla: 2nd and 3rd (Z = −2.324, p = 0.020), 2nd and 4th (Z = −2.626, p = 0.009).

3.4. Quality of Enhancement Curves

The enhancement curve of dynamic sequences for each patient was assessed. Changing the parameters of acquisitions of new dynamics during the initial phase until excretion, increased the effectiveness of the renal perfusion assessment.
The use of techniques shortening the duration of one dynamic, and techniques changing the direction of data collection (ENCASE), has improved the quality of the data obtained. There are no graph line jumps (Figure 11 and Figure 12a) at subsequent time points on the obtained signal intensity curves which are smoother and out of breathing artifacts (Figure 6 and Figure 12a). That illustrates how much information we lost in the first protocol, and how much information we can obtain with the fourth protocol. To improve this, we check TTP in the aorta (the time between highest signal intensity and point before contrast injection) in IntelliSpace Portal and ChopfMRU, and we checked TTP standard deviation for each protocol (Table 6). We used data in the aorta because we have a constant contrast injection flow and time-to-peak in the aorta should be approximately comparable in each patient without the difference in weight, age, height, or kidney disease. The obtained results show that with the newer protocol, we obtain lower values of standard deviation for TTP in the aorta (in ChopfMRU: first protocol SD = 14.560 vs. fourth protocol SD = 5.599; in IntelliSpace Portal: first protocol SD = 15.241 vs. fourth protocol SD = 5.506). This may indicate that with the latest protocol, we can achieve repeatable results with a possible low data loss.

4. Discussion

The present study evaluated imaging techniques for assessing kidney perfusion. The fourth protocol significantly improved image quality and renal perfusion assessment by suppressing breathing artifacts and increasing the number and frequency of consecutive dynamics during the initial phase until excretion. These findings have important clinical implications, as imaging techniques are critical for diagnosing and managing kidney disease.
The most significant technical problem concerning functional MRU imaging is obtaining the balance between spatial resolution, time resolution, and adjusting the acquisition matrix to the patient’s age [30]. Additionally, the qualitative analysis has problems with ROI (region of interest) positioning and respiratory artifacts. To address these limitations, techniques such as ENCASE and SENSE, and increasing the matrix size adequately to the patient’s size must be implemented [31,32].
To improve time resolution, we started using compressed sensing, a method for accelerated MR data acquisition based on the semi-random sampling of k-space. Adding compressed SENSE to multiple sequences in an exam can accelerate our examinations by 20–40%, which is very good for the patients and examination quality [33,34]. This is obvious because the shorter the examination time, the greater the patient’s comfort and, thus, the fewer motion artifacts adversely affecting the images. The other option to improve the quality of obtaining images could be a 4D MRI—RT respiratory self-gating sequence. This technique captions organ motion under free-breathing and automatic sorting obtaining data without external respiratory devices [35].
The proposed fourth protocol overcomes these mentioned above limitations by the highest matrix (384/384), the shortest time of the single dynamic sequence (8 s), and the highest number of dynamic sequences (40–50).
In the presented study, the analysis of the resolution based on corticomedullary differentiation showed a significant difference between the fourth and first protocol (Z = −3.423, p = 0.001), as well as between the second and third (Z = −2.323, p = 0.020), and second and fourth (Z = −4.212, p < 0.001) protocols. This evaluation is because diagnosis is based primarily on a visual assessment of the dynamics, and the temporal resolution greatly influences the quantitative evaluation of contrast intensity curves during postprocessing. Results obtained from the analysis of TTP in the aorta showed that with the latest, updated protocols, lower values of standard deviation were characterized, which may indicate more repeatable results (in ChopfMRU: first protocol SD = 14.560 vs. fourth protocol SD = 5.599; in IntelliSpace Portal: first protocol SD = 15.241 vs. fourth protocol SD = 5.506). In addition, SNR significantly differs in the medulla and cortex between the second and third (cortex: Z = −2.429, p = 0.015; medulla: Z = −2.324, p = 0.020), and the second and fourth (cortex: Z = −2.626, p = 0.009; medulla: Z = −2.626, p = 0.009) protocols. When we achieve optimal time resolution, renal function can be assessed more accurately. Based on our results’ lowest standard deviation (TTP in the aorta), we can assume that the fourth protocol can produce repeatable results with minimal data loss. All the changes introduced have led to better visibility of corticomedullary differentiation, as confirmed by visual and SNR evaluations. This improvement will help diagnosis, which is primarily based on qualitative evaluation. Obtained results illustrate that our changes helped us obtain higher-resolution images without compromising time resolution.
Moreover, the changes introduced in the proposed protocol allowed for a more accurate assessment of renal status, and the precise quantitative and qualitative analysis and calculations of the values of signal intensity curves in individual segments and parts of the kidneys were improved.
While the present study focused on MRI techniques, it is worth noting that other imaging modalities, such as CT and ultrasound, are also commonly used to diagnose and manage kidney disease [3,14,36]. The combination of fMRI with contrast-enhanced ultrasound (CEUS) may be particularly interesting. Hence, future studies could compare the efficacy of these imaging modalities to determine the most effective and appropriate technique for different clinical scenarios.
The findings of this study have potential implications for future research in the field of renal imaging. For instance, the fourth protocol presented in this study could be further optimized and improved upon in future studies using artificial intelligence (AI) and deep learning techniques [1].
It is important to note that the present study has some limitations. For instance, the study was limited to a small sample size, and the results may not be generalizable to larger populations or different clinical scenarios. Additionally, the study only evaluated one aspect of renal imaging, and future studies could explore other aspects of renal function imaging supported with AI [37,38,39,40].
In summary, there are several methods to improve the quality of the resulting images, including:
  • High-field MRI: using a higher magnetic field strength can improve the signal-to-noise ratio and overall image quality.
  • Parallel imaging: this technique allows data to be acquired from multiple coils simultaneously, reducing acquisition time and improving spatial resolution.
  • Motion correction: motion artifacts can negatively impact image quality, but motion compensation algorithms can compensate for patient movement and improve image quality.
  • Compressed sensing: this signal processing technique can reconstruct high-quality images from undersampled data.
  • Deep learning: the newest technique uses deep learning methods such as convolutional neural networks to improve image quality by reducing noise and enhancing contrast.

5. Conclusions

Functional magnetic resonance imaging (fMRU) is a non-invasive imaging modality that combines functional MRI and urography to provide a detailed picture of the functioning urinary tract. It is a promising technique with a few challenges that arise and need to be overcome. New technical opportunities should be introduced for everyday practice to improve MRU results.

Author Contributions

Conceptualization, M.G., D.Ś., A.S. and M.P.; methodology, M.G.; validation, M.G. and D.Ś.; formal analysis, M.G.; investigation, M.G.; resources, M.G.; writing—original draft preparation, M.G.; writing—review and editing, M.G. and D.Ś..; visualization, M.G.; supervision, D.Ś. and M.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Medical University of Gdansk (protocol code NKBBN/488/2018 and date of approval 24 October 2018).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on reasonable and qualified research request from the corresponding author. Data requestors will need to sign a data access agreement.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. McClennan, B.L. Imaging the Renal Mass: A Historical Review. Radiology 2014, 273, S126–S141. [Google Scholar] [CrossRef] [PubMed]
  2. Nicolau, C.; Aldecoa, I.; Bunesch, L.; Mallofre, C.; Sebastia, C. The Role of Contrast Agents in the Diagnosis of Renal Diseases. Curr. Probl. Diagn. Radiol. 2015, 44, 346–359. [Google Scholar] [CrossRef] [PubMed]
  3. Świętoń, D.; Bernard, W.; Grzywińska, M.; Czarniak, P.; Durawa, A.; Kaszubowski, M.; Piskunowicz, M.; Szurowska, E. A Comparability of Renal Length and Volume Measurements in MRI and Ultrasound in Children. Front. Pediatr. 2021, 9, 778079. [Google Scholar] [CrossRef] [PubMed]
  4. Dickerson, E.C.; Dillman, J.R.; Smith, E.A.; DiPietro, M.A.; Lebowitz, R.L.; Darge, K. Pediatric MR Urography: Indications, Techniques, and Approach to Review. RadioGraphics 2015, 35, 1208–1230. [Google Scholar] [CrossRef]
  5. Grenier, N.; Merville, P.; Combe, C. Radiologic imaging of the renal parenchyma structure and function. Nat. Rev. Nephrol. 2016, 12, 348–359. [Google Scholar] [CrossRef]
  6. Sudah, M.; Masarwah, A.; Kainulainen, S.; Pitkänen, M.; Matikka, H.; Dabravolskaite, V.; Aaltomaa, S.; Vanninen, R. Comprehensive MR Urography Protocol: Equally Good Diagnostic Performance and Enhanced Visibility of the Upper Urinary Tract Compared to Triple-Phase CT Urography. PLoS ONE 2016, 11, e0158673. [Google Scholar] [CrossRef]
  7. Rodigas, J.; Kirsch, H.; John, U.; Seifert, P.; Winkens, T.; Stenzel, M.; Mentzel, H.-J. Static and Functional MR Urography to Assess Congenital Anomalies of the Kidney and Urinary Tract in Infants and Children: Comparison With MAG3 Renal Scintigraphy and Sonography. Am. J. Roentgenol. 2018, 211, 193–203. [Google Scholar] [CrossRef]
  8. Grattan-Smith, J.D.; Chow, J.; Kurugol, S.; Jones, R.A. Quantitative renal magnetic resonance imaging: Magnetic resonance urography. Pediatr. Radiol. 2022, 52, 228–248. [Google Scholar] [CrossRef]
  9. Chen, Z.; Huang, H.; Yang, J.; Cai, H.; Yu, Y. The diagnostic value of magnetic resonance urography for detecting ureteric obstruction: A systematic review and meta-analysis. Ann. Med. 2020, 52, 275–282. [Google Scholar] [CrossRef]
  10. Kurugol, S.; Seager, C.M.; Thaker, H.; Coll-Font, J.; Afacan, O.; Nichols, R.C.; Warfield, S.K.; Lee, R.S.; Chow, J.S. Feed and wrap magnetic resonance urography provides anatomic and functional imaging in infants without anesthesia. J. Pediatr. Urol. 2019, 16, 116–120. [Google Scholar] [CrossRef]
  11. Taylor, A.; Nally, J.V. Clinical applications of renal scintigraphy. Am. J. Roentgenol. 1995, 164, 31–41. [Google Scholar] [CrossRef] [PubMed]
  12. Perez-Brayfield, M.R.; Kirsch, A.J.; Jones, R.A.; Grattan-Smith, J.D. A Prospective Study Comparing Ultrasound, Nuclear Scintigraphy and Dynamic Contrast Enhanced Magnetic Resonance Imaging in the Evaluation of Hydronephrosis. J. Urol. 2003, 170, 1330–1334. [Google Scholar] [CrossRef] [PubMed]
  13. Dillman, J.R.; Trout, A.T.; Smith, E.A. MR urography in children and adolescents: Techniques and clinical applications. Abdom. Imaging 2016, 41, 1007–1019. [Google Scholar] [CrossRef] [PubMed]
  14. Świȩtoń, D.; Grzywińska, M.; Czarniak, P.; Gołȩbiewski, A.; Durawa, A.; Teodorczyk, J.; Kaszubowski, M.; Piskunowicz, M. The Emerging Role of MR Urography in Imaging Megaureters in Children. Front. Pediatr. 2022, 10, 839128. [Google Scholar] [CrossRef] [PubMed]
  15. Chen, P.; Dong, B.; Zhang, C.; Tao, X.; Wang, P.; Zhu, L. The histogram analysis of apparent diffusion coefficient in differential diagnosis of parotid tumor. Dentomaxillofacial Radiol. 2020, 49, 20190420. [Google Scholar] [CrossRef] [PubMed]
  16. Zhu, W.; Ma, M.; Zheng, M.; Hao, H.; Yang, K.; Zhou, L.; Zhang, J.; Wang, H.; Li, X. Cine magnetic resonance urography for postoperative evaluation of reconstructive urinary tract after ileal ureter substitution: Initial experience. Clin. Radiol. 2020, 75, 480.e1–480.e9. [Google Scholar] [CrossRef]
  17. Riccabona, M. Pediatric MRU?its potential and its role in the diagnostic work-up of upper urinary tract dilatation in infants and children. World J. Urol. 2004, 22, 79–87. [Google Scholar] [CrossRef]
  18. Grattan-Smith, J.D.; Little, S.B.; Jones, R.A. MR urography evaluation of obstructive uropathy. Pediatr. Radiol. 2007, 38, 49–69. [Google Scholar] [CrossRef]
  19. Available, N.A.N. European Society of Urogenital Radiology (ESUR). Eur. Radiol. 2000, 10, E1–E26. [Google Scholar] [CrossRef]
  20. Ramamurthy, N.; Moosavi, B.; McInnes, M.; Flood, T.; Schieda, N. Multiparametric MRI of solid renal masses: Pearls and pitfalls. Clin. Radiol. 2014, 70, 304–316. [Google Scholar] [CrossRef]
  21. Esmaeili, M.; Esmaeili, M.; Ghane, F.; Alamdaran, A. Comparison Between Diuretic Urography (IVP) and Diuretic Renography for Diagnosis of Ureteropelvic Junction Obstruction in Children. Iran. J. Pediatr. 2016, 26, e4293. [Google Scholar] [CrossRef] [PubMed]
  22. Jones, R.A.; Schmotzer, B.; Little, S.B.; Grattan-Smith, J.D. MRU post-processing. Pediatr. Radiol. 2007, 38, 18–27. [Google Scholar] [CrossRef] [PubMed]
  23. Avni, E.; Bali, M.A.; Regnault, M.; Damry, N.; Degroot, F.; Metens, T.; Matos, C. MR urography in children. Eur. J. Radiol. 2002, 43, 154–166. [Google Scholar] [CrossRef] [PubMed]
  24. Koninklijke Philips, N.V. Encase. 2017. Available online: http://onprc.ohsu.edu/xd/education/schools/school-of-medicine/departments/clinical-departments/diagnostic-radiology/administration/mri-protocols/upload/R5-3-IS-ENCASE.pdf (accessed on 23 August 2019).
  25. Kanki, A.; Ito, K.; Tamada, T.; Noda, Y.; Yamamoto, A.; Tanimoto, D.; Sato, T.; Higaki, A. Corticomedullary differentiation of the kidney: Evaluation with noncontrast-enhanced steady-state free precession (SSFP) MRI with time-spatial labeling inversion pulse (time-SLIP). J. Magn. Reson. Imaging 2012, 37, 1178–1181. [Google Scholar] [CrossRef]
  26. Chuck, N.C.; Steidle, G.; Blume, I.; Fischer, M.A.; Nanz, D.; Boss, A. Diffusion Tensor Imaging of the Kidneys: Influence of b-Value and Number of Encoding Directions on Image Quality and Diffusion Tensor Parameters. J. Clin. Imaging Sci. 2013, 3, 53. [Google Scholar] [CrossRef]
  27. Welvaert, M.; Rosseel, Y. On the Definition of Signal-To-Noise Ratio and Contrast-To-Noise Ratio for fMRI Data. PLoS ONE 2013, 8, e77089. [Google Scholar] [CrossRef]
  28. Notohamiprodjo, M.; Dietrich, O.; Horger, W.; Horng, A.; Helck, A.D.; Herrmann, K.A.; Reiser, M.F.; Glaser, C. Diffusion Tensor Imaging (DTI) of the Kidney at 3 Tesla–Feasibility, Protocol Evaluation and Comparison to 1.5 Tesla. Investig. Radiol. 2010, 45, 245–254. [Google Scholar] [CrossRef]
  29. Khrichenko, D.; Darge, K. Functional analysis in MR urography—Made simple. Pediatr. Radiol. 2009, 40, 182–199. [Google Scholar] [CrossRef]
  30. Serai, S.D.; Hu, H.H.; Ahmad, R.; White, S.; Pednekar, A.; Anupindi, S.A.; Lee, E.Y. Newly Developed Methods for Reducing Motion Artifacts in Pediatric Abdominal MRI: Tips and Pearls. Am. J. Roentgenol. 2020, 214, 1042–1053. [Google Scholar] [CrossRef]
  31. Brodsky, E.K.; Bultman, E.M.; Johnson, K.M.; Horng, D.E.; Schelman, W.R.; Block, W.F.; Reeder, S.B. High-spatial and high-temporal resolution dynamic contrast-enhanced perfusion imaging of the liver with time-resolved three-dimensional radial MRI. Magn. Reson. Med. 2013, 71, 934–941. [Google Scholar] [CrossRef]
  32. Deshmane, A.; Gulani, V.; Griswold, M.A.; Seiberlich, N. Parallel MR imaging. J. Magn. Reson. Imaging 2012, 36, 55–72. [Google Scholar] [CrossRef]
  33. Geerts-Ossevoort, L.; De Weerdt, E.; Duijndam, A.; van IJperen, G.; Peeters, H.; Doneva, M.; Nijenhuis, M.; Huang, A. Compressed SENSE Speed done right. Every time. Philips FieldStrength Mag. 2018, p. 6619. Available online: https://www.usa.philips.com/c-dam/b2bhc/master/landing-pages/compressed-sense-redesign/brochure-compressed-spreads.pdf (accessed on 13 March 2019).
  34. Bardo, D.M.E.; Rubert, N. Radial sequences and compressed sensing in pediatric body magnetic resonance imaging. Pediatr. Radiol. 2021, 52, 382–390. [Google Scholar] [CrossRef] [PubMed]
  35. Tustison, N.J.; Avants, B.B.; Cook, P.A.; Zheng, Y.; Egan, A.; Yushkevich, P.A.; Gee, J.C. N4ITK: Improved N3 Bias Correction. IEEE Trans. Med. Imaging 2010, 29, 1310–1320. [Google Scholar] [CrossRef] [PubMed]
  36. Morin, C.E.; McBee, M.P.; Trout, A.T.; Reddy, P.P.; Dillman, J.R. Use of MR Urography in Pediatric Patients. Curr. Urol. Rep. 2018, 19, 93. [Google Scholar] [CrossRef] [PubMed]
  37. Lee, S.; Jung, S.; Jung, K.-J.; Kim, D.-H. Deep Learning in MR Motion Correction: A Brief Review and a New Motion Simulation Tool (view2Dmotion). Investig. Magn. Reson. Imaging 2020, 24, 196–206. [Google Scholar] [CrossRef]
  38. Pawar, K.; Chen, Z.; Shah, N.J.; Egan, G.F. Suppressing motion artefacts in MRI using an Inception-ResNet network with motion simulation augmentation. NMR Biomed. 2019, 35, e4225. [Google Scholar] [CrossRef]
  39. Sommer, K.; Saalbach, A.; Brosch, T.; Hall, C.; Cross, N.; Andre, J. Correction of Motion Artifacts Using a Multiscale Fully Convolutional Neural Network. Am. J. Neuroradiol. 2020, 41, 416–423. [Google Scholar] [CrossRef]
  40. Chavhan, G.B.; Babyn, P.S.; Vasanawala, S.S. Abdominal MR Imaging in Children: Motion Compensation, Sequence Optimization, and Protocol Organization. RadioGraphics 2013, 33, 703–719. [Google Scholar] [CrossRef]
Figure 1. Signal noise ratio measurements.
Figure 1. Signal noise ratio measurements.
Diagnostics 13 01786 g001
Figure 2. Model of the process of analysis.
Figure 2. Model of the process of analysis.
Diagnostics 13 01786 g002
Figure 3. Example of separation of the aorta.
Figure 3. Example of separation of the aorta.
Diagnostics 13 01786 g003
Figure 4. Example of separation of kidney.
Figure 4. Example of separation of kidney.
Diagnostics 13 01786 g004
Figure 5. Example of mathematical analysis.
Figure 5. Example of mathematical analysis.
Diagnostics 13 01786 g005
Figure 6. Example of analysis in the IntelliSpace Portal program. Example of analysis curves of 4th protocol obtained on IntelliSpace Portal 10.0.
Figure 6. Example of analysis in the IntelliSpace Portal program. Example of analysis curves of 4th protocol obtained on IntelliSpace Portal 10.0.
Diagnostics 13 01786 g006
Figure 7. Examples of evaluation of quality on the dynamic sequence in every protocol, visualization in time after contrast was injected.
Figure 7. Examples of evaluation of quality on the dynamic sequence in every protocol, visualization in time after contrast was injected.
Diagnostics 13 01786 g007
Figure 8. Box plot illustrates the changing of CNR for each protocol.
Figure 8. Box plot illustrates the changing of CNR for each protocol.
Diagnostics 13 01786 g008
Figure 9. Box plot illustrates the changing of SNR in medulla for each protocol.
Figure 9. Box plot illustrates the changing of SNR in medulla for each protocol.
Diagnostics 13 01786 g009
Figure 10. Box plot illustrates the changing of SNR in cortex for each protocol.
Figure 10. Box plot illustrates the changing of SNR in cortex for each protocol.
Diagnostics 13 01786 g010
Figure 11. Example of analysis curves of 1st protocol obtained on IntelliSpace Portal 10.0.
Figure 11. Example of analysis curves of 1st protocol obtained on IntelliSpace Portal 10.0.
Diagnostics 13 01786 g011
Figure 12. Example to obtaining enhancement curves (a) 1st protocol, (b) 4th protocol; obtained on Chop fMRU program.
Figure 12. Example to obtaining enhancement curves (a) 1st protocol, (b) 4th protocol; obtained on Chop fMRU program.
Diagnostics 13 01786 g012
Table 1. Evaluation of examination protocol.
Table 1. Evaluation of examination protocol.
1st Protocol2nd Protocol3rd Protocol4th Protocol
1Survey1Survey1Survey1Survey
2T1_TFE_IP_Cor_FB2T1_TFE_IP_Cor_FB2mDixon_Tra2T2W_TSE_Tra_HR
3T1_TFE_IP_Tra_FB3VISTA_COR3VISTA_COR_Sense3VISTA_COR_Sense
4BTFE_SPIR_COR_FB4BTFE_SPIR_SAG_FB4DWI_5b_Tra_navi4 1BTFE_SPIR_SAG_FB
5T2_TSE_TRA_FB5T2_TSE_HR_TRA_FB5T2W_TSE_Tra_HR5mDixon_Tra
6T2W_SPAIR_TRA_FB6STIR_Tra_FB6T2_SPAIR_TRA6DWI_5b_Tra_navi
7VISTA_COR7DWI_5b_Tra_navi7BTFE_SPIR_SAG_FB7STIR_Tra_FB
8sMRCP_3D_HR_COR8mDIXON_ TRA_FB8THRIVE_COR_3D8 2sMRCP_3D_HR_COR
9e-THRIVE_COR_FB9THRIVE_COR_FB9sT1W_FFE_IP9e-THRIVE_COR_FB
10T1_TFE_IP_COR_FB10T1_TFE_IP_COR_FB 10mDixon_Tra
TFE—turbo field echo; IP—in phase; FB—free breath, Navi—breathing navigator, TSE—turbo spin echo; SPAIR—spectral attenuated inversion recovery; VISTA—Volume isotropic turbo spin-echo acquisition = 3D-FAST SPIN ECHO; MRCP—magnetic resonance cholangiopancreatography; mDixon—time-consuming acquisition of in-phase and opposed-phase gradient-echo images; eTHRIVE—enhanced T1 high-resolution isotropic volume excitation; T1—the time constant for regrowth of longitudinal magnetization; T2—is the time constant for decay/dephasing of transverse magnetization; DWI—diffusion-weighted imaging. 1 This sequence is useful, when patient have uretero-pelvic junction structure obstruction. 2 This sequence is useful, when VISTA sequence have not enough good quality.
Table 2. Acquisition parameters of the dynamic sequence.
Table 2. Acquisition parameters of the dynamic sequence.
Parameters1st Protocol2nd Protocol3rd Protocol4th Protocol
Slice thickness/gap (mm)5334
Suppress fatSPAIRSPIRSPIRSPAIR
Flip angle10252510
Number of averages3111
TE/TR (ms)DefaultDefaultdefaultdefault
Matrix≈214/214≈214/214≈232/232≈384/384
Time (s) per dynamic≈10≈12≈8≈8
Breath holdFree breathFree breathFree breathFree breath
Sense-+++
ENCASE---+
Number of dynamics1025≈25–30≈40–50
Number of dynamics without contrast115–7>7
Delay between dynamics30 s30 s30 sFor the beginning, dynamics were acquired one by one, without delay. After a few minutes—30 s
PlaneCoronal with the angle of the oblique-coronal plane in long axis kidneyCoronal with the angle of the oblique-coronal plane in long axis kidneyCoronal with the angle of the oblique-coronal plane in long axis kidneyCoronal with a maximum of 5 degrees
Table 3. Results of visual assessment with a 4-point scale.
Table 3. Results of visual assessment with a 4-point scale.
Number of ProtocolVisual Assessment with a 4-Point Scale
NMinimumMaximumMeanMedianStandard Error
1st protocol202.004.002.8530.18
2nd protocol321.004.002.7830.13
3rd protocol221.004.003.2730.19
4th protocol173.004.003.7740.11
Where: N—the number of patients in the group, minimum—minimum value of results, maximum—maximum value of results, median—optimal prediction of values using a single number.
Table 4. Results of contrast-to-noise ratio (CNR).
Table 4. Results of contrast-to-noise ratio (CNR).
Number of ProtocolContrast to Noise Ratio (CNR)
NMinimumMaximumMeanMedianStandard Error
1st protocol201.3317.137.076,280.91
2nd protocol320.4315.736.155.290.72
3rd protocol221.8324.828.846.341.43
4th protocol170.3517.448.598.161.04
Where: N—the number of patients in the group, minimum—minimum value of results, maximum—maximum value of results, median—optimal prediction of values using a single number.
Table 5. Results of signal-to-noise ratio (SNR) in medulla and cortex.
Table 5. Results of signal-to-noise ratio (SNR) in medulla and cortex.
Number of ProtocolSignal to Noise Ratio (SNR) in MedullaSignal to Noise Ratio (SNR) in Cortex
NMinimumMaximumMeanMedianStandard ErrorMinimumMaximumMeanMedianStandard Error
1st protocol205.1886.1123.86717.894.396.5190.6830.9824.104.24
2nd protocol328.0934.7516.2212.091.3111.8245.7522.3819.551.61
3rd protocol227.2094.7626.3718.624.2412.48118.9435.2226.805.07
4th protocol175.9539.8123.1422.522.3813.1249.9931.7433.212.91
Where: N—the number of patients in the group, minimum—minimum value of results, maximum—maximum value of results, median—optimal prediction of values using a single number.
Table 6. Standard deviation obtained on TTP in the aorta.
Table 6. Standard deviation obtained on TTP in the aorta.
TTP Standard Deviation
IntelliSpace PortalChopfMRU
1st protocol15.24114.560
2nd protocol10.55013.768
3rd protocol9.21411.520
4th protocol5.5065.599
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Grzywińska, M.; Świętoń, D.; Sabisz, A.; Piskunowicz, M. Functional Magnetic Resonance Urography in Children—Tips and Pitfalls. Diagnostics 2023, 13, 1786. https://doi.org/10.3390/diagnostics13101786

AMA Style

Grzywińska M, Świętoń D, Sabisz A, Piskunowicz M. Functional Magnetic Resonance Urography in Children—Tips and Pitfalls. Diagnostics. 2023; 13(10):1786. https://doi.org/10.3390/diagnostics13101786

Chicago/Turabian Style

Grzywińska, Małgorzata, Dominik Świętoń, Agnieszka Sabisz, and Maciej Piskunowicz. 2023. "Functional Magnetic Resonance Urography in Children—Tips and Pitfalls" Diagnostics 13, no. 10: 1786. https://doi.org/10.3390/diagnostics13101786

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop